Insiders · DCPH

DCPH insider transactions

Deciphera Pharmaceuticals Inc. (DCPH) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for DCPH

• 726d
  EVP & Chief Medical Officer Sherman Matthew L was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  Chief Financial Officer Kelly Thomas Patrick was granted 34,157 shares and returned 72,029 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SVP, Chief Development Officer Pitman Jama was granted 20,163 shares and returned 53,951 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  Director Friedman Franklin Stuart closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Kelley Susan L.

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  EVP & Chief Scientific Officer Dhanak Dashyant was granted 25,913 shares and returned 184,088 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Martin John Richard

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  Chief Commercial Officer Martin Daniel C. was granted 20,163 shares and returned 43,951 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  Director Walsh Dennis Leo closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Bristol James Arthur

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Squarer Ron

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Allen Patricia L

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  President and CEO Hoerter Steven L. was granted 286,075 shares and returned 286,075 shares to the company, closing all direct ownership in the company (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 726d
  SEC Form 4 filed by Director Benz Edward J. Jr

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 775d
  Brightstar Associates Llc exercised 48,136 in-the-money shares at a strike of $0.01, increasing direct ownership by 0.21% to 23,107,844 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  Sherman Matthew L sold $40,840 worth of shares (2,615 units at $15.62) and was granted 17,275 shares, increasing direct ownership by 16% to 108,739 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  Pitman Jama was granted 19,725 shares and sold $35,405 worth of shares (2,267 units at $15.62), increasing direct ownership by 35% to 68,031 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  Kelly Thomas Patrick sold $47,009 worth of shares (3,010 units at $15.62) and was granted 17,275 shares, increasing direct ownership by 22% to 80,350 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  Dhanak Dashyant was granted 17,275 shares, increasing direct ownership by 12% to 158,175 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  SEC Form 4 filed by Hoerter Steven L.

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 839d
  Martin Daniel C. was granted 9,725 shares and sold $35,405 worth of shares (2,267 units at $15.62), increasing direct ownership by 16% to 55,118 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 850d
  Brightstar Associates Llc exercised 914,001 in-the-money shares at a strike of $0.01, increasing direct ownership by 4% to 23,059,708 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  Sherman Matthew L sold $35,234 worth of shares (2,435 units at $14.47), decreasing direct ownership by 3% to 94,079 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  Pitman Jama sold $23,499 worth of shares (1,624 units at $14.47), decreasing direct ownership by 3% to 50,573 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  SEC Form 4 filed by Walsh Dennis Leo

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  SEC Form 4 filed by Allen Patricia L

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  SEC Form 4 filed by Friedman Franklin Stuart

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  Kelly Thomas Patrick sold $35,234 worth of shares (2,435 units at $14.47), decreasing direct ownership by 4% to 66,085 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  Martin Daniel C. sold $23,499 worth of shares (1,624 units at $14.47), decreasing direct ownership by 3% to 47,660 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 872d
  SEC Form 4 filed by Squarer Ron

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 907d
  Kelly Thomas Patrick was granted 8,244 shares and sold $42,905 worth of shares (2,792 units at $15.37), increasing direct ownership by 9% to 68,520 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 907d
  Pitman Jama was granted 5,576 shares and sold $25,540 worth of shares (1,662 units at $15.37), increasing direct ownership by 8% to 52,197 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 907d
  Hoerter Steven L. sold $471,217 worth of shares (30,664 units at $15.37) and was granted 62,500 shares, increasing direct ownership by 78% to 72,763 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 907d
  Sherman Matthew L was granted 8,244 shares and sold $42,905 worth of shares (2,792 units at $15.37), increasing direct ownership by 6% to 96,514 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 907d
  Martin Daniel C. was granted 5,576 shares and sold $26,539 worth of shares (1,727 units at $15.37), increasing direct ownership by 8% to 49,284 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 920d
  Martin Daniel C. sold $223,755 worth of shares (17,801 units at $12.57), decreasing direct ownership by 28% to 45,435 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 951d
  Sherman Matthew L was granted 8,244 shares and sold $28,362 worth of shares (2,360 units at $12.02), increasing direct ownership by 7% to 90,628 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 951d
  Pitman Jama was granted 5,576 shares and sold $16,909 worth of shares (1,407 units at $12.02), increasing direct ownership by 9% to 48,283 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 951d
  Martin Daniel C. was granted 5,576 shares and sold $16,909 worth of shares (1,407 units at $12.02), increasing direct ownership by 7% to 62,884 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 951d
  Kelly Thomas Patrick was granted 8,244 shares and sold $27,833 worth of shares (2,316 units at $12.02), increasing direct ownership by 10% to 63,068 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 951d
  Hoerter Steven L. sold $259,256 worth of shares (21,573 units at $12.02) and was granted 62,500 shares (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 978d
  Sherman Matthew L sold $37,305 worth of shares (2,942 units at $12.68), decreasing direct ownership by 3% to 84,744 units (SEC Form 4)

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 993d
  SEC Form 4: Dhanak Dashyant was granted 140,900 shares

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1007d
  SEC Form 3 filed by new insider Dhanak Dashyant

  3 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Allen Patricia L

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Friedman Franklin Stuart

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Martin John Richard

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Walsh Dennis Leo

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Bristol James Arthur

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Benz Edward J. Jr

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Squarer Ron

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1081d
  SEC Form 4 filed by Kelley Susan L.

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1083d
  SEC Form 4 filed by Kelly Thomas Patrick

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1083d
  SEC Form 4 filed by Pitman Jama

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1083d
  SEC Form 4 filed by Sherman Matthew L

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1083d
  SEC Form 4 filed by Martin Daniel C.

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1083d
  SEC Form 4 filed by Flynn Daniel Lee

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1092d
  SEC Form 4 filed by Friedman Franklin Stuart

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1123d
  SEC Form 4 filed by Walsh Dennis Leo

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)
• 1173d
  SEC Form 4 filed by Hoerter Steven L.

  4 - Deciphera Pharmaceuticals, Inc. (0001654151) (Issuer)